课题基金 / 基金详情

项目摘要

项目成果

Thomas R Hawn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Tuberculosis (TB) is the leading cause of death in people living with HIV infection (PLHIV). Despite the discovery of Mycobacterium tuberculosis (Mtb) over 100 years ago and the availability of effective drugs for over 60 years, there remain formidable hurdles for controlling TB including the lack of a highly efficacious vaccine, long drug treatment regimens, prevention of infection, and killing dormant bacilli within macrophages. To address these problems, novel research and public health strategies need to be developed and coupled with enhanced training and local capacity building in high TB endemic countries. Kenya is one of 30 TB high burden countries which together constitute over 80% of global TB cases. The University of Nairobi (UoN), the Kenya Medical Research Institute (KEMRI) and the University of Washington (UW) propose a new TB-HIV Training Program (TBHTP) to address these needs. The TBHTP includes close partnerships in Kenya with the Ministry of Health National Tuberculosis Leprosy and Lung Disease Program (MoH NTLP), and the Kenya Pediatric Research Consortium (KEPRECON) – the research organization affiliated with the Kenya Pediatric Association (KPA). The primary goal of our program is to collaboratively develop training opportunities to address local needs in training and research capacity building. This partnership builds on a 35- year history of collaboration and training in HIV research between UW, KEMRI, and UoN. Although this partnership has been highly successful, TB has not been a high priority or focused goal of previous efforts. To build the capacity of KEMRI and the University of Nairobi (UoN) to conduct TB and TB-HIV co-infection research, we propose to implement a long-term training degree-earning track, a medium-term training non- degree track, and a short-term training track. During the 5-year period, we will train 5 UW MPH, 5 UoN Fellowship in Epidemiology, and 5 UoN PhD students working at KEMRI, UoN, or the MoH. We will also train 10 medium term non-degree scientists who have interest and potential in TB research will attend UW and take coursework in epidemiology and biostatistics or work in a laboratory for one to three months before returning to Kenya and engaging in a mentored research project. Finally, we will conduct short term workshops and provide on-line courses to build a critical mass of trained researchers who will create a supportive environment for research in TB. Together, these training opportunities will enhance local capacity and train the next generation of leaders who will discover novel research and public health strategies to combat the TB epidemic in Kenya.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development Core
  • 批准号:
    10425947
  • 项目类别:
  • 资助金额:
    $22.37万
  • 财政年份:
    2022
  • 负责人:
    Thomas R Hawn
  • 依托单位:
Development Core
  • 批准号:
    10595068
  • 项目类别:
  • 资助金额:
    $41.92万
  • 财政年份:
    2022
  • 负责人:
    Thomas R Hawn
  • 依托单位:
Administrative Core
  • 批准号:
    10653901
  • 项目类别:
  • 资助金额:
    $18.2万
  • 财政年份:
    2021
  • 负责人:
    Thomas R Hawn
  • 依托单位:
Administrative Core
  • 批准号:
    10271169
  • 项目类别:
  • 资助金额:
    $15.09万
  • 财政年份:
    2021
  • 负责人:
    Thomas R Hawn
  • 依托单位:
国内基金
海外基金
前列腺驻留菌Bacillus cereus促进前列腺增生的作用机制研究
  • 批准号:
    2026JJ81651
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢宇
  • 依托单位:
猪源益生菌Bacillus licheniformis PGM584缓解仔猪断奶腹泻的机制研究
  • 批准号:
    2025JJ50141
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    王启业
  • 依托单位:
基于Bacillus subtilis 细胞传感器介导的肠道环境中结直肠癌相关生物标志物的动态检测策略
  • 批准号:
    82372355
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    王永忠
  • 依托单位:
枯草芽孢杆菌Bacillus subtilis T5高效制备纳米硒及其合成机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
  • 依托单位: